Indianapolis, IN, United States of America

Kenneth James Ruterbories


Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1995-2004

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth James Ruterbories

Introduction

Kenneth James Ruterbories is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit platelet aggregation. With a total of 7 patents, Ruterbories has established himself as a key figure in innovation.

Latest Patents

Among his latest patents is the invention titled "Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation." This invention relates to certain spirocyclic compounds that are substituted with both basic and acidic functionality. These compounds are particularly useful in the inhibition of platelet aggregation, showcasing Ruterbories' commitment to advancing medical science.

Career Highlights

Ruterbories has had a distinguished career, working with prominent companies such as Eli Lilly and Company. His work has focused on creating innovative solutions that address critical health issues, particularly in the realm of cardiovascular health.

Collaborations

Throughout his career, Ruterbories has collaborated with talented individuals, including Matthew Joseph Fisher and Joseph A Jakubowski. These collaborations have contributed to the success of his inventions and the advancement of research in his field.

Conclusion

Kenneth James Ruterbories is a remarkable inventor whose work has had a significant impact on the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…